Pharma Journalist -

Samsung Biologics and Kanaph Therapeutics have entered into a strategic partnership to develop KNP-301, a bi-specific Fc fusion protein intended to treat retinal diseases. According…
Read More...

Novartis Gene Therapies recently received feedback from the US Food and Drug Administration (FDA) following their review of data from the STRONG study of the intrathecal (IT)…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to the Company’s supplemental New Drug Application(sNDA)for XALKORI…
Read More...

Dutch biotech company Micreos Human Health has enrolled the first patients in a Phase I/IIa, randomized, double-blind, placebo-controlled, parallel treated dose-ranging study to assess…
Read More...

InSysBio announces its collaboration with Genmab, an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the…
Read More...

Permira, the global private equity firm, today announced that a company backed by the Permira funds has agreed to acquire Neuraxpharm, a leading European specialty pharmaceutical…
Read More...

Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, announced the expansion of an exclusive global collaboration…
Read More...

Lantern Pharma, a clinical-stage biopharma company using its proprietary RADR artificial intelligence ("A.I.") platform to improve drug discovery & development and identify patients…
Read More...

Sanofi and GSK have signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine, beginning in 2021. “Today’s announcement…
Read More...

Cend Therapeutics, Inc., a clinical-stage biotech company, announced that it has acquired Impilo Therapeutics, Inc. The combination expands Cend’s drug delivery capabilities to create a…
Read More...